Evidence map›Paper›PMID 39110716›Full record

ArticlePloS one2024

Exposure to fine particulate matter in the New York City subway system during home-work commute.

Shams Azad, Pau Ferrer-Cid, Masoud Ghandehari

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shams AzadDepartment of Civil and Urban Engineering, New York University, Tandon School of Engineering, Brooklyn, New York, United States of America.ORCID 0000-0003-3683-7761
Pau Ferrer-CidDepartment of Computer Architecture, Universitat Politècnica de Catalunya, Barcelona, Spain.ORCID 0000-0003-2112-8516
Masoud GhandehariDepartment of Civil and Urban Engineering, New York University, Tandon School of Engineering, Brooklyn, New York, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The New York City (NYC) subway system accommodates 5.5 million daily commuters, and the environment within the subway is known to have high concentrations of fine particulate matter (PM2.5) pollution. Naturally, subway air pollution varies among individuals according to their mobility patterns, introducing the possibility of inequality in PM2.5 exposure. This study aims to evaluate individual and community-level exposure to subway PM2.5. We simulated the intracity home-to-work trip patterns using the Longitudinal Employer-Household Dynamics (LEHD) records of 3.1 million working commuters across 34,169 census blocks in four boroughs (Manhattan, Brooklyn, Queens, and the Bronx) of NYC. We incorporated the on-platform and on-train measured PM2.5 concentration data for the entire subway system. The mean underground platform concentration in the city was 139 μg/m3 with a standard deviation of 25 μg/m3, while the on-train concentration when underground was 99 μg/m3 with a standard deviation of 21 μg/m3. Using a network model, we determined the exposure of individual commuters during their daily home-work trips. We quantified the mean per capita exposure at the census block level by considering the proportion of workers within the blocks who rely on the subway for their work commute. Results indicate statistically significant weak positive correlation between elevated subway PM2.5 exposure and economically disadvantaged and racial minority groups.

Indexed as

Particulate MatterRailroadsAir PollutantsAir PollutionEnvironmental ExposureEnvironmental MonitoringHumansNew York CityAir PollutantsParticulate Matter

Identifiers

PMID39110716
PMCPMC11305539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.